LSA
IDXX icon

L & S Advisors’s Idexx Laboratories IDXX Stock Holding History

L & S Advisors’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,075
Closed -$2.02M – 302
2021
Q4 		$2.02M Buy
3,075
+392
+15% +$246K 0.22% 134
2021
Q3 		$1.67M Sell
2,683
-916
-25% -$616K 0.18% 159
2021
Q2 		$2.27M Sell
3,599
-472
-12% -$261K 0.24% 128
2021
Q1 		$1.99M Sell
4,071
-409
-9% -$205K 0.23% 148
2020
Q4 		$2.24M Buy
4,480
+248
+6% +$111K 0.26% 133
2020
Q3 		$1.66M Buy
+4,232
New +$1.56M 0.23% 136

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

L & S Advisors's IDXX Position: Q1 2022 in Review

L & S Advisors sold out of Idexx Laboratories (IDXX) in Q1 2022, closing a stake of 3,075 shares — an estimated $2.02M sold.

L & S Advisors first reported a position in IDXX in Q3 2020 and held it in 6 quarters. The position peaked at $2.27M in Q2 2021. 1,032 funds tracked by Wall St. Rank hold IDXX as of Q1 2022.

  • L & S Advisors reported no remaining Idexx Laboratories position as of Q1 2022 after selling out during the quarter.
  • L & S Advisors sold 3,075 Idexx Laboratories shares in Q1 2022, an estimated $2.02M.
  • L & S Advisors first reported a position in Idexx Laboratories in Q3 2020 and held it in 6 quarters.
  • L & S Advisors's Idexx Laboratories position peaked at $2.27M in Q2 2021.
  • 1,032 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2022.

Based on L & S Advisors's 13F filing for Q1 2022, filed 11 May 2022.